On Aug. 31, 2023, study results published in JAMA found that psilocybin treatment was associated with a clinically significant sustained reduction in depressive symptoms and functional disability, without serious adverse events.

These findings add to increasing evidence that psilocybinﾗwhen administered with psychological supportﾗmay hold promise as a novel intervention for MDD.